Discovery of novel anti-angiogenesis agents. Part 8: Diaryl thiourea bearing 1 H -indazole-3-amine as multi-target RTKs inhibitors
- 1 December 2017
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 141, 373-385
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81573285)
- Natural Science Basic Research Plan in Shaanxi Province of China (2015JQ8312)
- Fundamental Research Funds for the Central Universities (2015qngz13)
This publication has 25 references indexed in Scilit:
- Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directionsEuropean Journal of Pharmacology, 2016
- Deciphering key features in protein structures with the new ENDscript serverNucleic Acids Research, 2014
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisAngiogenesis, 2010
- Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agentsEuropean Journal of Medicinal Chemistry, 2010
- Discovery of novel taspine derivatives as antiangiogenic agentsBioorganic & Medicinal Chemistry Letters, 2010
- The scientific contributions of M. Judah Folkman to cancer researchNature Reviews Cancer, 2008
- COBALT: constraint-based alignment tool for multiple protein sequencesBioinformatics, 2007
- A new family of angiogenic factorsCancer Letters, 2006
- A review on pro- and anti-angiogenic factors as targets of clinical interventionPharmacological Research, 2006
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996